Loading...
GLP-1 Receptor Agonists: Nonglycemic Clinical Effects in Weight Loss and Beyond
OBECTIVE: Glucagon-like peptide-1 (GLP-1) receptor agonists are indicated for treatment of type 2 diabetes since they mimic the actions of native GLP-1 on pancreatic islet cells, stimulating insulin release, while inhibiting glucagon release, in a glucose-dependent manner. The observation of weight...
Na minha lista:
| Udgivet i: | Obesity (Silver Spring) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4692091/ https://ncbi.nlm.nih.gov/pubmed/25959380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.21107 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|